Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)


Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly. 

31 year old woman with Eosinophilic Esophagitis. This lady’s symptoms were resolved within two months of taking LDN and she took it through pregnancy, delivering a healthy baby. 

76 year old man with Myasthenia Gravis. This gentleman had failed traditional treatment for this rare disease and was prescribed low dose naltrexone, he then made slow but steady improvement and was able to resume his life.  

44 year old man with Glycogen Storage Disorder (GSD VII). Another rare disorder that responded somewhat to traditional treatment but this gentleman had significant improvement after starting low dose naltrexone. 

62 year old woman with Pemphigus Vulgaris. This lady had been treated with chemotherapy immunosuppressant medication and wasn’t doing particularly well. Once she started on LDN her rare disorder went into remission, two years later she was still in remission. 

65 year old woman with Crackly Brain or Middle Ear Myoclonus (MEM) - this lady had had botox injections in her face to try to stop the pain and discomfort of her condition.   Within two months on Low Dose Naltrexone she was feeling much better and within four months  she was having less spasm in the right side of her face, fewer headaches and requiring less Botox injections and the crackling stopped. 

The term “zebra” is used by doctors to refer to a disease or condition that is rare, unexpected, or surprising and these six cases meet that description in their rarity. All were helped by Low Dose Naltrexone and these people were able to resume their lives. 

For more presentations please visit https://ldnresearchtrust.org/ldn-conferences